KRAS and neoplasm: The tumor-derived exosomes from the KRAS-mutant NSCLC patients have been found to transform naïve CD4+CD25−T cells to CD4+FoxP3+ Treg-like cells, a process independent of cytokine signaling (Fig. 2).